ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Viyash Scientific Limited announced receipt of Italian regulatory approval for its subsidiary Alivira Animal Health's acquisition of BioForLife Italia S.r.l. The transaction completion timeline is extended.
Viyash Scientific Ltd is incorporating a new subsidiary, Alivira Vietnam Company Limited, with a cash investment of ₹3.82 Crore. This expands its global subsidiary structure.
Viyash Scientific Limited will convert intercompany loans into equity in its subsidiary, Alivira Animal Health Limited, valued at ₹400.02 Crore. The move strengthens the subsidiary's capital structure.
Viyash Scientific Ltd's subsidiary executed a share purchase agreement to acquire BioForLife Italia S.r.l. The transaction is valued at approximately EUR 16.976 million.